Prof Bart Westerman speaks to ecancer about an abstract that he presented at AACR 2022 regarding the development of a 'drug atlas'.

He explains that the 'drug atlas' creates a way to identify the synergistic interactions of drugs and allows a filter of preclinical data for the most effective combinations with the least toxicities.

Prof Westerman details how the model was developed and how it is progressing to someday be applied in the clinic.